850012-45-2

Upstream product

• 895542-86-6 (4-bromo-2-tert-butylphenyl)ethylamine 
• 75-03-6 ethyl iodide 
• 850012-44-1 4-bromo-(2-tert-butyl)aniline 

Downstream Products

• 895542-83-3 3-tert-butyl-4-diethylaminophenylboronic acid 
• 850012-46-3 3-tert-butyl-4-diethylaminobenzaldehyde 

Relevant academic research and scientific papers

NOVEL RAR RECEPTOR AGONIST LIGANDS AND USE THEREOF IN HUMAN MEDICINE AND COSMETICS

The invention relates to compounds corresponding to general formula (I) below: to the compositions containing same, to methods for the preparation thereof and to the use thereof in pharmaceutical compositions for use in human or veterinary medicine, or else in cosmetic compositions.

Pharmaceutical/cosmetic compositions comprising novel ligands that activate RAR receptors

Novel ligand compounds that activate RAR receptors have the following structural formula (I): and are suited for formulation into pharmaceutical compositions useful in human or veterinary medicine, or, alternatively, into cosmetic compositions.

NOVEL LIGANDS THAT MODULATE RAR RECEPTORS, AND USE THEREOF IN HUMAN MEDICINE AND IN COSMETICS

The present invention relates to novel compounds corresponding to the general formula (I) below: to compositions containing them, to processes for preparing them and to their use in pharmaceutical compositions intended for use in human or veterinary medic